Adjustment for phenotypic bcl2/c-myc double-hit scores in the case of FOXP1 showed that it retained its prognostic significance in those DLBCL, NOS cases scored 0 and 1 (and outperformed failure to achieve combined metabolic and morphologic remission in cases scored 0), but neither expression of FOXP1 nor failure to achieve complete combined metabolic and morphologic remission were of prognostic significance with respect to OS in phenotypic bcl2/c-myc double-hit score 2 DLBCL, NOS cases (data not shown in detail). Here, BCL2 is linked to diffuse large B-cell lymphoma.